Source position verification and dosimetry in HDR brachytherapy using an EPID.

PURPOSE Accurate treatment delivery in high dose rate (HDR) brachytherapy requires correct source dwell positions and dwell times to be administered relative to each other and to the surrounding anatomy. Treatment delivery inaccuracies predominantly occur for two reasons: (i) anatomical movement or (ii) as a result of human errors that are usually related to incorrect implementation of the planned treatment. Electronic portal imaging devices (EPIDs) were originally developed for patient position verification in external beam radiotherapy and their application has been extended to provide dosimetric information. The authors have characterized the response of an EPID for use with an (192)Ir brachytherapy source to demonstrate its use as a verification device, providing both source position and dosimetric information. METHODS Characterization of the EPID response using an (192)Ir brachytherapy source included investigations of reproducibility, linearity with dose rate, photon energy dependence, and charge build-up effects associated with exposure time and image acquisition time. Source position resolution in three dimensions was determined. To illustrate treatment verification, a simple treatment plan was delivered to a phantom and the measured EPID dose distribution compared with the planned dose. RESULTS The mean absolute source position error in the plane parallel to the EPID, for dwells measured at 50, 100, and 150 mm source to detector distances (SDD), was determined to be 0.26 mm. The resolution of the z coordinate (perpendicular distance from detector plane) is SDD dependent with 95% confidence intervals of ± 0.1, ± 0.5, and ± 2.0 mm at SDDs of 50, 100, and 150 mm, respectively. The response of the EPID is highly linear to dose rate. The EPID exhibits an over-response to low energy incident photons and this nonlinearity is incorporated into the dose calibration procedure. A distance (spectral) dependent dose rate calibration procedure has been developed. The difference between measured and planned dose is less than 2% for 98.0% of pixels in a two-dimensional plane at an SDD of 100 mm. CONCLUSIONS Our application of EPID dosimetry to HDR brachytherapy provides a quality assurance measure of the geometrical distribution of the delivered dose as well as the source positions, which is not possible with any current HDR brachytherapy verification system.

[1]  Richard Lee,et al.  An investigation of a new amorphous silicon electronic portal imaging device for transit dosimetry. , 2002, Medical physics.

[2]  J. Williamson,et al.  Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. , 2012, Medical physics.

[3]  T. Kron,et al.  Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer , 2007, Australasian Physics & Engineering Sciences in Medicine.

[4]  J. Valentin,et al.  Protecting people against radiation exposure in the event of a radiological attack , 2005, Annals of the ICRP.

[5]  Anatoly Rosenfeld,et al.  Verification of the plan dosimetry for high dose rate brachytherapy using metal-oxide-semiconductor field effect transistor detectors. , 2007, Medical physics.

[6]  P. Hoskin,et al.  High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  N Suchowerska,et al.  A plastic scintillation dosimeter for high dose rate brachytherapy , 2006, Physics in medicine and biology.

[8]  J. Lambert,et al.  In vivo dosimeters for HDR brachytherapy: a comparison of a diamond detector, MOSFET, TLD, and scintillation detector. , 2007, Medical physics.

[9]  J. Duan,et al.  Real-time monitoring and verification of in vivo high dose rate brachytherapy using a pinhole camera. , 2001, Medical physics.

[10]  Ron S Sloboda,et al.  Quality assurance measurements of a-Si EPID performance. , 2004, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[11]  A. Yorozu,et al.  New method for obtaining position and time structure of source in HDR remote afterloading brachytherapy unit utilizing light emission from scintillator , 2009, Journal of applied clinical medical physics.

[12]  J. Williamson,et al.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2004 .

[13]  D. Georg,et al.  Dose-response characteristics of an amorphous silicon EPID , 2005 .

[14]  Peter B Greer,et al.  Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapy. , 2003, Medical physics.

[15]  R. Sloboda,et al.  Consequences of the spectral response of an a-Si EPID and implications for dosimetric calibration. , 2005, Medical physics.

[16]  M van Herk,et al.  Comparison of ghosting effects for three commercial a-Si EPIDs. , 2006, Medical physics.

[17]  B. McCurdy,et al.  Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging device. , 2001, Medical physics.

[18]  K. Tanderup,et al.  Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  J. Williamson,et al.  Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. , 1998, Medical physics.

[20]  Tomas Kron,et al.  An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  M. V. van Herk,et al.  Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification. , 2006, Medical physics.

[22]  J Duan,et al.  In vivo urethral dose measurements: a method to verify high dose rate prostate treatments. , 2000, Medical physics.

[23]  J J Sonke,et al.  Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device. , 2003, Medical physics.

[24]  L. Beaulieu,et al.  Clinical prototype of a plastic water-equivalent scintillating fiber dosimeter array for QA applicationsa). , 2008, Medical physics.

[25]  K R Russell,et al.  Dose calculation in brachytherapy for a source using a primary and scatter dose separation technique , 1996, Physics in medicine and biology.

[26]  J. Valentin.  Preface, Main Points, Introduction, Chapters 2 and 3 , 2005 .

[27]  M. V. van Herk,et al.  Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT. , 2007, International journal of radiation oncology, biology, physics.

[28]  N. Suchowerska,et al.  High dose-rate brachytherapy source localization: positional resolution using a diamond detector. , 2003, Physics in medicine and biology.

[29]  J. Bowsher,et al.  Tracking brachytherapy sources using emission imaging with one flat panel detector. , 2009, Medical physics.